About US
Contact us
-
Pick the Commish: Hamburg, Gottlieb, Glimcher and Abernethy make the final fourThe FiercePharma voter search for FDA commissioner is now down to four—with women as three of the remaining candidates. Former FDA commissioner Peggy Hamburg, current deputy commissioner Amy Aberneth2020/12/11
-
As Pfizer's first COVID-19 vaccine doses roll across the U.S., analysts size up the hurdles aheadAftera“historically eventful”fewdays for COVID-19 vaccines—featuring key meetings at the FDA and CDC, plusan emergency authorization—a massive immunization programkickedoff Monday morning. Vaccinatio2020/12/10
-
Fierce Pharma Politics—Amid Pfizer, U.S. coronavirus vaccine talks, Azar suggests using Defense Production Act to snare dosesWelcome to theFiercePharmapolitical roundup, where each Monday we’ll highlight developments in Washington, D.C., and elsewherethat could affect drug pricing and howdrugmakersoperate. As Pfizer ships2020/12/10
-
With Pfizer shot spoken for, U.S. snaps up 100M more Moderna COVID-19 vaccine dosesWith oneCOVID-19 vaccine authorized in the U.S. and another candidate speeding toward an OK this week, Operation Warp Speed is hustling to lock down hundreds of millions ofshots for a massive U.S.imm2020/12/8
-
AvKARE bottles mix Viagra generics with antidepressant, triggering recallA generic drugmaker with a Rolodex full of federal clients is pulling an antidepressant and an erectile dysfunction med after the two were packaged together in the same bottles. Pulaski, Tennessee-ba2020/12/8
-
JSR's CDMO arm plans $150M biologics facility in Research Triangle alongside unnamed pharma partnerBiologics production has mushroomed in recent years with massive investments from big biopharma and contract manufacturing alike. Just over a month after its parent company pledged to expand clinical2020/12/4
-
The $38B pie: Pfizer, Moderna COVID-19 vaccines set for lion's share of 2021 salesWith the first COVID-19 vaccinations expected to start in the coming weeks, 2021 is shaping up to be quite a year for the companies leading the vaccine race, with major blockbuster revenues on the li2020/12/4
-
Merck cashes in on Moderna COVID-19 vaccine enthusiasm with sale of equity stakeWhen Merck invested $100 million in cash and stock in Moderna back in 2015, and then another $125 million three years later, the term “mRNA” was barely known outside of biotech circles. But now2020/12/3
-
Lonza plots 2 manufacturing suites for antibody-drug conjugates at Switzerland siteThe search for next-gen oncology therapies has sparked an arms race in biopharma to find the next big thing—whether that's in cell and gene therapies or promising antibody-drug conjugates (ADCs). Eye2020/12/3
-
CDMO Sterling plots buyout of antibody-drug conjugate specialist in play at next-gen oncology marketA little more than two months after bolstering its manufacturing presence in the U.S., CDMO Sterling Pharma Solutions is expanding its scope once more, this time in the realm of next-gen cancer meds.2020/12/2